Información del producto
Nombre:MK 0686
Marca:Biosynth
Descripción:MK 0686 is a novel drug candidate that belongs to the class of conjugates. It is comprised of an acetylcholinesterase inhibitor and a quinoline-2-carboxylic acid. The acetylcholinesterase inhibitor blocks the breakdown of acetylcholine, which may reduce pain. MK 0686 has been shown in animal models to be reactive with cyp1a and human data has shown that it can inhibit the metabolism of drugs metabolized by cyp1a. This drug candidate also has the ability to form monoclonal antibodies when injected into humans or animals, which may be used for immunotherapy against various cancers. MK 0686 is catalysed by microsomal proteins, which are liver enzymes that break down foreign substances in the blood for disposal, and this process may affect how quickly this drug is absorbed into the bloodstream.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:486.8 g/mol
Fórmula:C22H19ClF4N2O4
Pureza:Min. 95%